ASSESSMENT OF DRUG PRESCRIPTION PATTERN IN ST-SEGMENT AND NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS

Background: An assessment of drug prescription pattern in patients who were diagnosed with ST and Non-ST Segment myocardial infarction and who met the inclusion criteria and exclusion criteria was carried out in the Malla Reddy Narayana Multispeciality Hospital, Hyderabad.

Aim: To study drug prescription patterns in patients with ST and Non ST- segment elevation myocardial infarction.

Methods: A prospective observational study for a period of 5 months was conducted in the cardiology department of Malla reddy hospital. The percentage of the data was calculated using Microsoft Excel 2016.

Results: A total number of 55 patients were enrolled in the study of which 36 [65%] were male patients and 19 [35%] were female patients. The NSTEMI patients are more in number when compared to STEMI patients. The age group between 50-70 are mostly facing MI and later comes the 40-49 age population. While, 20- 30 years age group are seen in exceptional cases with other diseases being main cause [ blood clots]. The drugs prescribed for STEMI and NSTEMI in India are LIPIVAS[Statin] with 75% prescribed for patients. Then comes the ECOSPRIN [Anti-platelet medicine] prescribed for 70% of patients, CLOPIVAS [Anti-platelet medicine] prescribed for 65% of patients, MITNOX [Anticoagulant] for 63%, AGGXIBLOC and METODER [β-BLOCKER] with 50% prescribed. And MAVIK [ACE inhibitor] with least i.e., 45% prescribed. The overall prescription patterns involved in our study is satisfactory.